FIGS, Inc.

FIGS, Inc. (FIGS) Market Cap

FIGS, Inc. has a market capitalization of .

No quote data available.

CEO: Catherine Eva Spear

Sector: Consumer Cyclical

Industry: Apparel - Manufacturers

IPO Date: 2021-05-27

Website: https://www.wearfigs.com

FIGS, Inc. (FIGS) - Company Information

Market Cap: -|Sector: Consumer Cyclical

Company Profile

FIGS, Inc. functions as a direct-to-consumer enterprise specializing in healthcare apparel and lifestyle merchandise across the United States. The company innovates and distributes a comprehensive selection of medical uniforms, complemented by a diverse array of non-scrub items. These offerings span functional pieces like lab coats, under-scrubs, compression socks, footwear, and masks, extending to activewear, loungewear, and outerwear such as performance leggings, sports bras, various tops (including super-soft pima cotton options), vests, and jackets. Customers can access and purchase FIGS' products directly through its integrated digital platform, which encompasses both its official website and mobile application. Founded in 2013, FIGS, Inc. is headquartered in Santa Monica, California.

Analyst Sentiment

70%
Buy

From 9 Active Polls

1Y Forecast: $18.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$17

Median

$18

High Bound

$19

Average

$18

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$18.00
▲ +68.22% Upside
Low Target
$17.00
59% Risk
Median Target
$18.00
68% Mid
High Target
$19.00
78% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 FIGS INC CLASS A (FIGS) — Investment Overview

🧩 Business Model Overview

FIGS designs and sells medical/workwear apparel (notably scrubs) through a mixed channel model. The value chain centers on (1) product development and fabric/fit design, (2) sourcing and manufacturing execution, (3) branding and merchandising, and (4) distribution across direct-to-consumer (primarily e-commerce) and wholesale channels (partnering with retailers, health-related distributors, and institutions depending on the market). Customer stickiness is driven less by regulatory barriers and more by repeat purchase behavior tied to comfort, durability, sizing consistency, and style preferences—supported by FIGS’ ability to refresh product assortments and maintain a premium positioning relative to basic uniform offerings.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly generated from apparel unit sales, with monetization supported by:
  • Direct-to-consumer sales: Higher product economics potential relative to wholesale, with margins influenced by logistics efficiency, marketing efficiency, and return rates.
  • Wholesale/partner sales: More scale-oriented revenue with typically lower per-unit economics, but reduced direct customer acquisition burden and broader shelf access.
Margin drivers are anchored in:
  • Gross margin discipline: fabric and sourcing costs, product mix (premium categories tend to command better pricing power), and markdown management.
  • Operating leverage: ability to spread fixed costs (design, e-commerce operations, brand overhead) over a growing revenue base.
  • Unit economics: marketing spend efficiency and inventory/returns management, which directly affect contribution margin.

🧠 Competitive Advantages & Market Positioning

FIGS’ most durable moat is intangible assets—specifically a premium brand identity and product design focus that translates into repeat purchasing for a subset of clinicians and other medical/workwear customers who value comfort, fit, and durability. The business also benefits from a distribution/merchandising capability (its ability to place product in front of demand via its channel mix), though the structural switching costs are generally moderate in apparel. Competitive benchmarking:
  • Dickies / workwear-uniform brands: Broader workwear heritage with stronger mass-market penetration and pricing flexibility.
  • Cherokee / traditional uniform suppliers: Historically embedded in healthcare purchasing ecosystems with extensive channel relationships.
  • Jaanuu (premium scrub e-commerce brand): Competes in the premium segment with similar value propositions around design and comfort.
How FIGS differs: FIGS concentrates on a premium, fashion-meets-function positioning within medical/workwear, leaning heavily on product differentiation and direct customer experience. Where traditional uniform brands often emphasize price, compliance, and bulk ordering, FIGS emphasizes fit/comfort and assortment freshness—attempting to make scrubs a repeat-purchase “comfort product” rather than a commodity.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, FIGS’ growth thesis is supported by several secular and market-expansion themes:
  • Healthcare workforce expansion and staffing churn: Greater demand for scrubs and related apparel from a growing and rotating clinician population.
  • Shift toward “premium uniform” spend: A long-run tendency for certain segments to trade up from basic apparel to higher-comfort, better-fitting products.
  • Category expansion: Growth from extending beyond core scrubs into adjacent apparel categories (e.g., tops, outerwear, and other clinician/workwear items) to increase customer lifetime value.
  • Channel leverage: Scaling direct commerce capabilities while selectively expanding wholesale/partner reach to diversify demand sources and reduce reliance on any single acquisition channel.
  • International and broader segment penetration: Extending premium positioning to new geographies and non-traditional medical/workwear segments where comfort and design can command willingness to pay.
The key operational requirement for sustained growth is balancing assortment expansion with inventory discipline to protect margins.

⚠ Risk Factors to Monitor

  • Fashion/apparel demand volatility: Product cycles and style preferences can change; misjudging assortment can lead to markdowns.
  • Competition and pricing pressure: Large uniform brands can use scale and procurement leverage to defend price, while premium peers can compete for attention with differentiated designs.
  • Inventory and working capital risk: Apparel is exposed to forecasting error and return dynamics, which can pressure cash conversion.
  • Supply chain and quality control: Fabric consistency, manufacturing quality, and throughput issues can degrade the comfort/durability proposition and increase returns.
  • Channel mix and customer acquisition economics: Over-reliance on paid marketing can raise volatility in contribution margins if customer acquisition costs rise.
  • Intellectual property imitation: Unlike pharmaceuticals or medical devices, the barrier to entry is lower; competitors can replicate designs, pressuring differentiation.

📊 Valuation & Market View

Markets typically evaluate premium apparel/consumer-healthwear companies using a mix of:
  • Revenue growth trajectory and its durability (especially repeat purchase behavior and improving customer lifetime value).
  • Gross margin sustainability (driven by sourcing, product mix, and markdown control).
  • Operating leverage (scaling fixed costs and maintaining efficient fulfillment and marketing spend).
  • Quality of earnings indicators such as inventory levels and cash conversion trends.
In this sector, valuation expectations usually compress when growth slows without margin support, or when inventory/returns patterns indicate weakening demand. Conversely, valuation can expand when operating discipline demonstrates that premium positioning can be maintained while scaling.

🔍 Investment Takeaway

FIGS’ long-term investment case rests on its ability to maintain a premium product-and-brand intangible advantage in medical/workwear, supported by channel execution that can scale without eroding gross margin. The company’s moat is not anchored in regulatory barriers, but in repeat-purchase dynamics driven by fit, comfort, and durability, alongside distribution/merchandising capability. The central challenge is protecting inventory discipline and contribution margins while competing against both mass-uniform incumbents and other premium apparel entrants.

⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"FIGS reported Q1’26 revenue of $159.9M and net income of $6.29M (EPS $0.04), with gross margin improving to 67.7%. On a YoY basis, revenue rose from $124.9M in Q1’25 to $159.9M (+28.0%), and net income swung from a loss of $0.10M to a profit of $6.29M (improved by ~$6.39M). On a QoQ basis, revenue declined from $201.9M in Q4’25 to $159.9M (-20.8%), while net income decreased from $18.5M to $6.29M (-66.0%), indicating seasonality and/or a softer quarter. Profitability improved versus the prior year: net margin strengthened to 3.93% from -0.08% a year ago, while operating margin remained positive at 2.80% (up meaningfully vs the operating loss in Q1’25). Over the last four quarters, margins appear more resilient than early-2025, supported by higher gross margin (generally mid-to-high 60%s). Cash flow quality weakened sequentially: operating cash flow was -$3.2M in Q1’26 versus +$60.9M in Q4’25 (and +$9.2M in Q1’25). The company still ended the quarter with substantial liquidity—$277.0M cash & short-term investments—and continued shareholder returns via buybacks (repurchased $8.8M of stock in the quarter). Total shareholder returns look strong given the stock’s 1Y price appreciation of +296%."

Revenue Growth

Good

YoY Q1’26 revenue grew to $159.9M (+28.0% vs $124.9M in Q1’25). QoQ revenue declined to $159.9M (-20.8% vs $201.9M in Q4’25), consistent with seasonality/step-down.

Profitability

Good

Net margin improved to 3.93% in Q1’26 from -0.08% in Q1’25, with EPS turning positive ($0.04). QoQ profit fell (net income -66.0% vs Q4’25), but operating income stayed positive at $4.48M; gross margin rose to 67.7%.

Cash Flow Quality

Neutral

Operating cash flow was -$3.2M in Q1’26 (vs +$60.9M in Q4’25; vs +$9.2M in Q1’25). Buybacks of $8.8M occurred, and free cash flow was -$5.6M, indicating weaker near-term cash conversion.

Leverage & Balance Sheet

Good

Balance sheet remains resilient with strong liquidity ($277.0M cash & short-term investments) and modest leverage (total debt $60.6M; net debt -$13.7M). Total assets were $563.4M, and equity was stable at $430.6M.

Shareholder Returns

Strong

Capital appreciation is exceptional: +296.3% 1Y. The company also executed buybacks (-$8.8M in Q1’26). No dividend payments were reported.

Analyst Sentiment & Valuation

Fair

Street valuation implies mixed risk/reward: consensus target is $12.92 vs current price $16.17 (implying downside to target). Despite strong momentum, the current valuation metrics (e.g., high P/S) suggest expectations are elevated.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

FIGS delivered a strong Q1 2026 beat, with net revenue up 28% YoY to $159.9M and active customer growth accelerating to 12% (3M+ active customers for the first time). Profitability improved materially: adjusted EBITDA margin was 8.7%, +140 bps YoY and +170 bps ahead of their expectation. Management attributed outperformance to product-led momentum (scrubwear +27% with FORMx fabric mix nearly doubling; durable FIBREx expanding), marketing engagement (multi-platform virality cited during Nurses Week), and healthcare’s replenishment-driven, nondiscretionary demand that supports rising repeat frequency. On guidance, FIGS raised FY26 net revenue growth to +14%–16% and adjusted EBITDA margin to 13.0%–13.2%, with Q2 net revenue growth in the low-20% range. Key risks remain tariff/freight uncertainty and fuel-driven outbound cost pressure; they also delayed benefit recognition from ~$20M IEEPA refunds pending processing clarity.

AI IconGrowth Catalysts

  • Scrubwear leadership: net revenues +27% with scrubwear at 79% of revenue
  • FORMx fabric adoption: fabric mix nearly doubled YoY; continued color expansion
  • Durable FIBREx fabrication: debuted via Winter Olympics collection; planned more meaningful spotlight in 2H
  • Non-scrubwear acceleration: +31% YoY (21% of net revenues) driven by underscrubs/outerwear layering system
  • Wider pant silhouettes + head-to-toe coordination driving cross-sell across selling occasions
  • Spring color drop performed exceptionally well; returning 'espresso' based on community demand
  • Maternity styles relaunch for first time in 3 years
  • Star Wars collection collaboration ahead of next franchise movie

Business Development

  • Formal partnership with Noah Wyle (incremental investment cited in Q1 marketing)
  • Brand partnership: first Drinkware collaboration with Owala
  • Expanded healthcare community presence via on-campus activations at Howard University, University of Houston, and McGill University (Toronto)
  • Teams expansion: Team store launched March, integrated into FIGS e-commerce platform for seamless ordering

AI IconFinancial Highlights

  • Net revenues: $159.9M (+28% YoY), ahead of outlook calling for low-20% growth
  • Active customers: accelerated to +12% YoY; surpassed 3M active customers for first time
  • AOV: +4% to $124 (pricing actions early Q1 + favorable mix); less price elasticity than planned
  • Gross margin: 67.7% (+10 bps vs prior period), in line with outlook; tariff pressure higher sequentially and less favorable product mix offset by pricing/efficiency
  • Selling expense: $36.4M (22.8% of net revenues) vs 26.2% last year (fixed/variable leverage from fulfillment optimization and outbound carrier diversification savings despite parcel surcharges)
  • Marketing expense: $29.5M (18.4% of net revenues) vs 14.5% last year; higher due to Winter Olympics campaign costs and incremental investment areas
  • Adjusted EBITDA margin: 8.7% vs 7.3% prior year (+140 bps YoY); also stated +170 bps better than adjusted EBITDA margin expectations/guide
  • Operating margin: 2.8% vs -0.2% last year
  • Diluted EPS: $0.03 vs breakeven diluted EPS prior year (net income $6.3M vs net loss $100k)
  • Tax rate: effective tax rate outlook ~20% for 2026 vs prior 25% outlook; compared to 27.4% last year (excess tax benefit from stock price appreciation vs incentive grant prices)
  • Tariff framework update: prior assumption 15% global tariffs reduced to reflect only Section 122 tariff of 10% through July 24, then 15% thereafter; gross margin outlook unchanged after offsetting inbound freight/oil and duty drawback pause
  • IEEPA tariff refunds: action taken on what was paid; approximately $20M refunds not embedded until clarity on timing/process

AI IconCapital Funding

  • Share repurchases: ~$8.8M in Q1 at weighted avg price $15.38
  • Repurchase program remaining capacity: ~$43M available for future repurchases
  • Cash/net cash position: $277M net cash, cash equivalents, and short-term investments at quarter end
  • Capex: $2.4M in Q1 (software capitalization and leasehold improvements); larger community hub outlays planned later in year

AI IconStrategy & Ops

  • Inventory: $139.4M (+6% YoY); targeting ~200 inventory days by year-end
  • Fulfillment center optimization (post Q3 2024 opening) driving fixed and variable cost leverage
  • Outbound carrier diversification strategy continued to yield YoY savings despite parcel surcharges
  • Pricing actions in January on ~1/3 of styles; ongoing elasticity monitoring; no near-term pricing move of same magnitude indicated
  • Supplier partnership evolution and new inventory planning tools using real-time demand signals
  • International rollout cadence: 15 new European markets in March; 12 additional Asia-Pacific markets in April; now present in 85 international markets vs 32 end of 2024
  • Community hubs optimization: 5 locations all performing well; focus on refining assortment/assisting core styles/sizes for 3 locations opened end of last year; on track to open 4 new hubs in back half 2026

AI IconMarket Outlook

  • Full-year 2026 net revenue guidance: +14% to +16% (raised vs prior +10% to +12%)
  • Q2 2026 net revenue growth guidance: up in the low-20% range YoY
  • Full-year gross margin: expecting modest improvement from 66.5% level in fiscal 2025
  • Quarterly gross margin cadence: Q2 modest YoY decline from 67% last year; Q3 more meaningful decline; Q4 large YoY improvement
  • Full-year operating margin guidance: 7.8% to 8.0% (raised from 7.6% to 7.9%)
  • Full-year adjusted EBITDA margin guidance: 13.0% to 13.2% (raised from 12.7% to 12.9%)
  • Expected Q2 adjusted EBITDA margin: ~13.5% vs 12.9% prior year period
  • Tariff assumption cadence: 10% through July 24 deadline (Section 122), then 15% thereafter for rest of year (per updated outlook)

AI IconRisks & Headwinds

  • Sequentially higher tariff pressure during Q1; tariffs remain dynamic for forecasting
  • Gross margin headwinds from higher inbound freight due to oil price surge
  • Tariff-related pause in duty drawback program offsets more favorable tariff outlook; gross margin unchanged overall guidance
  • Refund benefit from IEEPA tariff actions (~$20M) not currently embedded pending clarity on processing timing
  • Outbound/fuel impacts: outbound freight negatively impacted by fuel costs despite carrier diversification savings
  • Geopolitical and regional demand variability: sequential slower yet still strong growth in Middle East; growth rebounded in Canada after prior year sentiment-driven softness

Q&A: Analyst Interest

  • Topic: Underlying demand/consumer behavior shift from Q4 to Q1 and early Q2; did anything change? Management tied upside to three drivers: product innovation, marketing virality (e.g., Nurses Week), and replenishment-driven nondiscretionary demand. They emphasized repeat frequency improving and stated momentum is “sustainable.”
  • Topic: Teams growth path and whether it will “grind higher” or step-function upward; near-term levers? Management said Teams is growing but they’re “a bit away” from the larger opportunity. They highlighted Teams store technology, broader institutional fit (universities to hospitals), and a relationship-building sales approach.
  • Topic: Pricing elasticity and promotional cadence for 2Q/back half; impact of earlier price increases? Management said pricing in January hit ~1/3 of styles, tracked elasticity showed results more favorable than assumed, and that demand supports updating the rest-of-year outlook. They framed the move as effectively one-time and indicated no same-magnitude near-term pricing.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the FIGS Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — FIGS, Inc. (FIGS) Financial Profile